ANTX
Price
$1.08
Change
+$0.01 (+0.93%)
Updated
Jun 24 closing price
Capitalization
32.59M
43 days until earnings call
RANI
Price
$0.50
Change
+$0.01 (+2.04%)
Updated
Jun 24 closing price
Capitalization
16.68M
43 days until earnings call
Interact to see
Advertisement

ANTX vs RANI

Header iconANTX vs RANI Comparison
Open Charts ANTX vs RANIBanner chart's image
AN2 Therapeutics
Price$1.08
Change+$0.01 (+0.93%)
Volume$57.58K
Capitalization32.59M
Rani Therapeutics Holdings
Price$0.50
Change+$0.01 (+2.04%)
Volume$226.23K
Capitalization16.68M
ANTX vs RANI Comparison Chart in %
Loading...
ANTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANTX vs. RANI commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANTX is a Buy and RANI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (ANTX: $1.07 vs. RANI: $0.49)
Brand notoriety: ANTX and RANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANTX: 22% vs. RANI: 51%
Market capitalization -- ANTX: $32.59M vs. RANI: $16.68M
ANTX [@Biotechnology] is valued at $32.59M. RANI’s [@Biotechnology] market capitalization is $16.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANTX’s FA Score shows that 1 FA rating(s) are green whileRANI’s FA Score has 0 green FA rating(s).

  • ANTX’s FA Score: 1 green, 4 red.
  • RANI’s FA Score: 0 green, 5 red.
According to our system of comparison, ANTX is a better buy in the long-term than RANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANTX’s TA Score shows that 4 TA indicator(s) are bullish while RANI’s TA Score has 4 bullish TA indicator(s).

  • ANTX’s TA Score: 4 bullish, 4 bearish.
  • RANI’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RANI is a better buy in the short-term than ANTX.

Price Growth

ANTX (@Biotechnology) experienced а -0.93% price change this week, while RANI (@Biotechnology) price change was -5.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.91%. For the same industry, the average monthly price growth was +35.46%, and the average quarterly price growth was +17.29%.

Reported Earning Dates

ANTX is expected to report earnings on Aug 07, 2025.

RANI is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANTX($32.6M) has a higher market cap than RANI($16.7M). ANTX YTD gains are higher at: -22.464 vs. RANI (-64.234). ANTX (-47.8M) and RANI (-48.83M) have comparable annual earnings (EBITDA) . ANTX has more cash in the bank: 67.1M vs. RANI (15.9M). RANI has higher revenues than ANTX: RANI (1.2M) vs ANTX (0).
ANTXRANIANTX / RANI
Capitalization32.6M16.7M195%
EBITDA-47.8M-48.83M98%
Gain YTD-22.464-64.23435%
P/E RatioN/AN/A-
Revenue01.2M-
Total Cash67.1M15.9M422%
Total DebtN/A25.7M-
FUNDAMENTALS RATINGS
ANTX: Fundamental Ratings
ANTX
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANTXRANI
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ANTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BILI19.910.17
+0.86%
Bilibili
NTWK2.910.01
+0.34%
NetSol Technologies
FAST41.30-0.19
-0.46%
Fastenal Co
KRP14.29-0.32
-2.19%
Kimbell Royalty Partners LP
SGMT8.36-0.36
-4.13%
Sagimet Biosciences

ANTX and

Correlation & Price change

A.I.dvisor tells us that ANTX and NKTX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANTX and NKTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANTX
1D Price
Change %
ANTX100%
-2.73%
NKTX - ANTX
26%
Poorly correlated
-1.41%
CSLLY - ANTX
26%
Poorly correlated
+0.69%
RANI - ANTX
25%
Poorly correlated
-2.33%
CERO - ANTX
24%
Poorly correlated
-23.60%
IRON - ANTX
23%
Poorly correlated
+0.14%
More

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with XENE. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
-2.33%
XENE - RANI
35%
Loosely correlated
-1.75%
ADVM - RANI
32%
Poorly correlated
-0.89%
DRUG - RANI
31%
Poorly correlated
-0.81%
UBX - RANI
31%
Poorly correlated
-8.53%
OCUL - RANI
30%
Poorly correlated
+2.83%
More